Jan 28, 2025
 in 
Hot Stocks 🔥

GSK Scores £50m Cancer Vaccine Deal With Oxford Uni | Nemo

Name of opportunity: 👀

GSK PLC-SPON ADR

£50m partnership 💸

GSK stock has crept up in price, going up by 3.59% in the past day and 5.69% in the past week, which might be because of the company's huge £50m deal with Oxford University for a cancer vaccination that has been recently announced. GSK stock is also recovering nicely from a dip in the past month, as it is up 5.50%  in the past month overall.

GSK is performing well financially, with strong cash flow, EBITDA, and revenue. Analysts are currently calling this stock a ‘buy.’  Should you invest?

How hot is this investment opportunity? 🔥🔥🔥

Analysts predict the price of GSK might increase from $35.50 to $40.28 in the next 12 months. If you invested $1000, you might profit $134.65.

GSK has recently signed a £50m deal with Oxford University to develop a cancer prevention vaccine. This collaboration aims to last for at least 3 years as GSK and Oxford University join forces to help create a vaccination that may stop cancer before it develops. This would be a world-changing medicine, targeting precancerous cells to stop them ever progressing to cancer. 

This collaboration might have had an impact on GSK’s stock price, as it highlights a strong commitment to innovation, and might position GSK strongly in the market for cancer treatments. This can boost investor confidence which may impact the share price.

Additionally, this deal can set GSK up for future revenue growth, which might be another reason why this stock is going up in price. If this partnership ends in a successful vaccine, it can set GSK up for long-term success and growth. 

Moreover, GSK partnering with a prestigious institution such as  Oxford University, may have strengthened GSK’s reputation within the pharmaceutical industry. This may have attracted more investors, boosting the stock price. 

Pharmaceutical company 💉

GSK is a British multinational biotechnology and pharmaceutical company that is headquartered in Brentford, West London, United Kingdom.

Which neme?: 🔍

Made In The UK’, ‘Pharma’.

Download Nemo Money to check out GSK PLC-SPON ADR. New users can grab our registration bonus up to a maximum of $50 on first deposit. Terms and conditions apply.

Han Tan

Han Tan is a seasoned financial journalist and news presenter renowned for his expertise in global markets. With a career highlighted by interviews with prominent figures and recognition from major media outlets like CNN and Reuters, he delivers insightful analysis on market news and macroeconomic trends to clients and international audiences. Han's sharp commentary on currencies, stocks, and commodities is familiar to viewers of Bloomberg TV Malaysia, BFM 89.9, and NTV7, cementing his sterling reputation in the industry.